JBIOJBIONASDAQ
Loading
JBIO Revenue Growth (YoY Quarterly)•+0.00%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+8447.68%
+7293.2pp
+5855.01%
+4700.6pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +4.66% | +4.28% | +3360.46% | +1154.44% | +8447.68% |
| Weighted Average Shares Diluted Growth | +4.66% | +4.28% | +3360.46% | +1154.44% | +5855.01% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | -159.31% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | -159.46% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -36.95% | -27.42% | +100.52% | +122.57% | +335.42% |
| Book Value per Share Growth | -33.28% | -20.83% | -93.83% | -82.24% | -94.91% |
| Debt Growth | -38.22% | -59.69% | +16.30% | +38.33% | +73.62% |
| R&D Expense Growth | -91.41% | -100.00% | +6.11% | +62.06% | +1761.53% |
| SG&A Expenses Growth | +15.12% | -24.99% | +7.00% | +288.66% | +32.18% |
1 / 2